Clinical Trial Update: Intracoronary Stem Cell Therapy in Patients With Acute Myocardial Infarction (SCAMI) [Phase 2]

View source ↗

Summary

This update notes completion of a Phase 2 trial evaluating intracoronary stem cell therapy in patients with acute myocardial infarction (SCAMI).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Infarction

Drugs mentioned

• Intracoronary stem cell therapy

Snippet

Sponsor: University of Ulm | Conditions: Acute Myocardial Infarction, Coronary Artery Disease | Phase 2 | Status: COMPLETED